CN103442719A - 含透明质酸或透明质酸盐的水溶液 - Google Patents

含透明质酸或透明质酸盐的水溶液 Download PDF

Info

Publication number
CN103442719A
CN103442719A CN2012800110602A CN201280011060A CN103442719A CN 103442719 A CN103442719 A CN 103442719A CN 2012800110602 A CN2012800110602 A CN 2012800110602A CN 201280011060 A CN201280011060 A CN 201280011060A CN 103442719 A CN103442719 A CN 103442719A
Authority
CN
China
Prior art keywords
hyaluronate
aqueous solution
hyaluronic acid
ferrum
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800110602A
Other languages
English (en)
Chinese (zh)
Inventor
能见健司
岛田贤太郎
守川忠志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denki Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denki Kagaku Kogyo KK filed Critical Denki Kagaku Kogyo KK
Publication of CN103442719A publication Critical patent/CN103442719A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CN2012800110602A 2011-03-02 2012-03-02 含透明质酸或透明质酸盐的水溶液 Pending CN103442719A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011045770 2011-03-02
JP2011-045770 2011-03-02
PCT/JP2012/055424 WO2012118191A1 (ja) 2011-03-02 2012-03-02 ヒアルロン酸またはその塩を含む水溶液

Publications (1)

Publication Number Publication Date
CN103442719A true CN103442719A (zh) 2013-12-11

Family

ID=46758116

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012800110602A Pending CN103442719A (zh) 2011-03-02 2012-03-02 含透明质酸或透明质酸盐的水溶液

Country Status (4)

Country Link
JP (1) JP5957439B2 (ja)
KR (1) KR20140024863A (ja)
CN (1) CN103442719A (ja)
WO (1) WO2012118191A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021076076A1 (en) * 2019-10-17 2021-04-22 Betatech Medikal Cihazlar Sanayi Mumessillik Ic Ve Dis Ticaret Limited Sirketi Cystitis solution comprising hyaluronic acid and polyethylene glycol and production method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10212303A (ja) * 1997-01-31 1998-08-11 Denki Kagaku Kogyo Kk ヒアルロン酸ナトリウム水溶液用安定化組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
JP2006104461A (ja) * 2004-09-10 2006-04-20 Seikagaku Kogyo Co Ltd グリコサミノグリカン画分中の不純物の除去方法
EP2039777A4 (en) * 2006-06-07 2011-11-30 Kyowa Hakko Bio Co Ltd PROCESS FOR PURIFYING HYALURONIC ACID SALT
JP2009011315A (ja) * 2007-06-05 2009-01-22 Mitsubishi Rayon Co Ltd ヒアルロン酸の製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10212303A (ja) * 1997-01-31 1998-08-11 Denki Kagaku Kogyo Kk ヒアルロン酸ナトリウム水溶液用安定化組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WONG,S.F. ET AL: "The role of superoxide and hydroxyl radicals in the degradation of hyaluronic acid induced by metal ions and by ascorbic acid", 《JOURNAL OF INORGANIC BIOCHEMISTRY》 *

Also Published As

Publication number Publication date
KR20140024863A (ko) 2014-03-03
JP5957439B2 (ja) 2016-07-27
WO2012118191A1 (ja) 2012-09-07
JPWO2012118191A1 (ja) 2014-07-07

Similar Documents

Publication Publication Date Title
CN102238953A (zh) 用于治疗骨关节病的可注射的聚脱氧核糖核苷酸组合物
CN105796589A (zh) 用于治疗关节的组合物和方法
CN103491967A (zh) 含有透明质酸的人工唾液
CN102740860B (zh) 通读诱导剂以及无义突变型遗传疾病的治疗药物
CN103442718A (zh) 含透明质酸或透明质酸盐的水溶液
RU2013157823A (ru) Фармацевтические композиции на основе shk и способы их получения и использования
CN103547273A (zh) 一种向具有树脂制筒部的注射器内注入含透明质酸或透明质酸盐的水溶液而成的预充式注射器
CN103442719A (zh) 含透明质酸或透明质酸盐的水溶液
CN103442720A (zh) 含透明质酸或透明质酸盐的水溶液
CN103442721A (zh) 含透明质酸或透明质酸盐的水溶液
EP3881841B1 (en) Pharmaceutical composition
CN105435221B (zh) 一种针对血管内皮生长因子的人源化抗体的药物组合物
CN106389359B (zh) 供注射用的贝利司他药物组合物及其制备方法
EP2222312B1 (en) Aqueous iron dextran preparation having one or more para-hydroxybenzoate compounds and/or salts thereof
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
FI98891C (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
CN102188367A (zh) 一种甘精胰岛素注射液及其制备方法
CN104906127B (zh) 一种有效碘含量稳定性增强的聚维酮碘复方制剂及其制备方法
CN101697973B (zh) 一种注射用头孢硫脒制剂及其制备方法
CN106853252A (zh) 曲贝替定药物组合物及其制备方法
CN111991354A (zh) 一种复方阿莫西林粉及其制备方法
RU2592975C1 (ru) СПОСОБ ПОЛУЧЕНИЯ КОМПОЗИЦИЙ НА ОСНОВЕ ВЫСОКОМОЛЕКУЛЯРНОГО ГЕПАРИНА С АМИНОКИСЛОТАМИ И 3-d МЕТАЛЛАМИ
CN103405392B (zh) 一种夫西地酸钠冻干粉针剂专用注射剂及其制备方法
JP3236608B2 (ja) ブレオマイシン類の安定な水溶液
CN107737101A (zh) 一种鱼腥草素的注射用药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20131211

RJ01 Rejection of invention patent application after publication